首頁 › 自體免疫疾病 › 紐約州 › New York City
New York City, NY 的 自體免疫疾病 臨床試驗
19 項針對 自體免疫疾病 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Memorial Sloan Kettering Cancer Center, New York
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
Daratumumab in Primary Antiphospholipid Syndrome
招募中1/2 期
- NYU Langone, New York
- Hospital for Special Surgery, New York
- Weill Cornell, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Abatacept for the Treatment of Giant Cell Arteritis
招募中3 期
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
招募中3 期
- Icahn School of Medicine at Mount Sinai, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Columbia University Irving Medical Center, New York
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
招募中1/2 期
- Columbia University, New York
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
招募中3 期
- Site Number - 1036, New York
- Site Number - 1034, New York
Autoimmune and Autoinflammatory Genetics Study
招募中觀察性研究歡迎健康志工
- NYC H+H/Bellevue, New York
- NYU Langone Health, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- 還有 3 項
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
招募中1/2 期
- Columbia University, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Montefiore Medical Center, New York
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
招募中1 期
- Columbia University Irving Medical Center, New York
Biologics And Clinical Immunology Cohort at Sinai
招募中觀察性研究
- Mount Sinai, New York
Allergy and Immunology Natural History Study
招募中觀察性研究歡迎健康志工
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
其他城市的 自體免疫疾病 試驗
- Houston, TX21 項研究
- Washington, DC19 項研究
- Philadelphia, PA16 項研究
- Durham, NC15 項研究
- Boston, MA13 項研究
- Chicago, IL12 項研究
- Los Angeles, CA12 項研究
- Dallas, TX9 項研究
- Atlanta, GA8 項研究
- Portland, OR8 項研究
- Milwaukee, WI8 項研究
- Cleveland, OH8 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。